Company: NIVFW
Filing Date: 2025-06-20
Form Type: 6-K
Source: 0001213900-25-056234
Chunk: 0

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-20
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File Number: 001-42004

NEWGENIVF GROUP LIMITED

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)</div>

Indicate by check mark whether the registrant files or will
file annual reports under cover Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒ Form
40-F ☐

EXPLANATORY NOTE</div>

As of the date of this report, the total issued and
outstanding shares of the Company (the “Shares”) is 4,324,565, consisting of 4,304,037 Class A ordinary shares and 20,528
Class B ordinary shares. This represents an increase from the 1,050,840 Shares disclosed in the Company’s most recent
prospectus filed on June 3, 2025. The increase is attributable to:

| (i) | exercises of warrants and convertible notes by an existing warrant 
 holder and convertible note holder; and                            |

| (ii) | share issuances pursuant to the Company’s Common Shares 
 Purchase Agreement with White Lion Capital, LLC.        |

<div align='center'>1

SIGNATURE</div>

Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Date: June 20, 2025

| NewGenIvf Group Limited |                                    |
| By:                     | /s/ Wing Fung Alfred Siu           |
| Name:                   | Wing Fung Alfred Siu               |
| Title:                  | Chairman of the Board and Director |

<div align='center'>2</div>